4XKX image
Deposition Date 2015-01-12
Release Date 2015-02-04
Last Version Date 2024-11-20
Entry Detail
PDB ID:
4XKX
Title:
Crystal structure of BACE1 in complex with 2-aminooxazoline 3-azaxanthene inhibitor 28
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.80 Å
R-Value Free:
0.22
R-Value Work:
0.19
R-Value Observed:
0.19
Space Group:
P 61 2 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Beta-secretase 1
Gene (Uniprot):BACE1
Mutations:R56K, R57K
Chain IDs:A
Chain Length:411
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
Development of 2-aminooxazoline 3-azaxanthenes as orally efficacious beta-secretase inhibitors for the potential treatment of Alzheimer's disease.
Bioorg.Med.Chem.Lett. 25 767 774 (2015)
PMID: 25613679 DOI: 10.1016/j.bmcl.2014.12.092

Abstact

The β-site amyloid precursor protein (APP) cleaving enzyme 1 (BACE1) is one of the most hotly pursued targets for the treatment of Alzheimer's disease. We used a structure- and property-based drug design approach to identify 2-aminooxazoline 3-azaxanthenes as potent BACE1 inhibitors which significantly reduced CSF and brain Aβ levels in a rat pharmacodynamic model. Compared to the initial lead 2, compound 28 exhibited reduced potential for QTc prolongation in a non-human primate cardiovascular safety model.

Legend

Protein

Chemical

Disease

Primary Citation of related structures